Abstract
Background
High‐density lipoprotein (HDL) could enhance inflammation in atherogenesis when inflammatory response is present, and the activity of paraoxonase and antioxidant in HDL in the elderly is significantly decreased. There might be a different role for high‐density lipoprotein cholesterol (HDL‐C) between different age groups in patients with coronary heart disease (CHD).
Methods
For this study, 225 inpatients with CHD (coronary atherosclerosis stenosis ≥ 50% on ≥ 1 major coronary arteries by coronary angiography), and 80 without CHD; 120 resting unstable angina patients, and 68 with stable angina were consecutively recruited. Risk factors were analyzed for CHD and resting unstable angina.
Results
High‐density lipoprotein cholesterol in resting unstable angina was higher than that in stable angina (1.24 ± 1.05 versus 1.05 ± 0.29 mmol/L, p = 0.032). After adjustment for age, sex, physical inactivity, hypertension, diabetes, C‐reactive protein, triglycerides, total cholesterol (TC) and low‐density lipoprotein cholesterol (LDL‐C) the adjusted odds ratio (OR) (95% CI) of resting unstable angina was 10.19 (2.18–47.6, p = 0.003) for HDL‐C. Risk factors were further investigated in different age groups. Adjusted OR of CHD associated with HDL‐C in < 55‐year‐old group was 0.09 (0.01–0.66, p = 0.018), in ≥ 55‐year‐old group it was 0.55 (0.08–3.82, p > 0.05). Adjusted OR of resting unstable angina associated with high HDL‐C was 19.24 (2.86–129.4, p = 0.002) in patients aged ≥ 55 years.
Conclusions
Elevated HDL‐C might be an independent risk factor for resting unstable angina, even though HDL‐C could play a much more important role in protection against coronary stenosis in younger or middle‐aged persons. Copyright © 2007 Wiley Periodicals, Inc.
Keywords: high‐density lipoprotein cholesterol, resting unstable angina, coronary heart disease
Full Text
The Full Text of this article is available as a PDF (237.0 KB).
References
- 1. Ansell BJ, Watson KE, Fogelman AM, Navab M, Fonarow GC: High‐density lipoprotein function: recent advances. J Am Coll Cardiol 2005; 46: 1792–1798. [DOI] [PubMed] [Google Scholar]
- 2. Navab M, Ananthramaiah GM, Reddy ST, Van Lenten BJ, Ansell BJ, et al.: The double jeopardy of HDL. Ann Med 2005; 37: 173–178. [DOI] [PubMed] [Google Scholar]
- 3. Manninen V, Elo MO, Frick MH, Haapa K, Heinonen OP, et al.: Lipid alterations and decline in the incidence of coronary heart disease in the Helsinki Heart Study. JAMA 1988; 260: 641–651. [PubMed] [Google Scholar]
- 4. Robins SJ, Collins D, Wittes JT, Papademetriou V, Deedwania PC, et al.: Relation of gemfibrozil treatment and lipid levels with major coronary events. JAMA 2001; 285: 1585–1591. [DOI] [PubMed] [Google Scholar]
- 5. Downs JR, Clearfield M, Weis S, Whitney E, Shapiro DR, et al.: Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels. JAMA 1998; 279: 1615–1622. [DOI] [PubMed] [Google Scholar]
- 6. Rubins HB, Robins SJ, Collins D, Fye CL, Anderson JW, et al.: Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high‐density lipoprotein cholesterol. N Engl J Med 1999; 341: 410–418. [DOI] [PubMed] [Google Scholar]
- 7. Agerholm‐Larsen B, Nordestgaard BG, Steffensen R, Jensen G, Tybjaerg‐Hansen A: Elevated HDL cholesterol is a risk factor for ischemic heart disease in white women when caused by a common mutation in the cholesteryl ester transfer protein gene. Circulation 2000; 101: 1907–1912. [DOI] [PubMed] [Google Scholar]
- 8. Bittner V, Simon JA, Fong J, Blumenthal RS, Newby K, et al.: Correlates of high HDL cholesterol among women with coronary heart disease. Am Heart J 2000; 139: 288–296. [DOI] [PubMed] [Google Scholar]
- 9. Milochevitch C, Khalil A: Study of the paraoxonase and platelet‐activating factor acetylhydrolase activities with aging. Prostaglandins Leukot Essent Fatty Acids 2001; 65: 241–246. [DOI] [PubMed] [Google Scholar]
- 10. Seres I, Paragh G, Deschene E, Fulop T Jr, Khalil A: Study of factors influencing the decreased HDL associated PON1 activity with aging. Exp Gerontol 2004; 39: 59–66. [DOI] [PubMed] [Google Scholar]
- 11. Corti MC, Guralnik JM, Salive ME, Harris T, Field TS, et al.: HDL cholesterol predicts coronary heart disease mortality in older persons. JAMA 1995; 274: 539–544. [PubMed] [Google Scholar]
- 12. Curb JD, Abbott RD, Rodriguez BL, Masaki K, Chen R, et al.: A prospective study of HDL‐C and cholesteryl ester transfer protein gene mutations and the risk of coronary heart disease in the elderly. J Lipid Res 2004; 45: 948–953. [DOI] [PubMed] [Google Scholar]
- 13. Jaouad L, de Guise C, Berrougui H, Cloutier M, Isabelle M, et al.: Age‐related decrease in high‐density lipoproteins antioxidant activity is due to an alteration in the PON1's free sulfhydyl groups. Atherosclerosis 2006; 185: 191–200. [DOI] [PubMed] [Google Scholar]
- 14. Navab M, Anantharamaiah GM, Fogelman AM: The role of high‐density lipoprotein in inflammation. Trends Cardiovasc Med 2005; 15: 158–161. [DOI] [PubMed] [Google Scholar]
- 15. Miwa K, Fujita M, Sasayama S: Recent insights into the mechanisms, predisposing factors, and racial difference of coronary vasospasm. Heart Vessels 2005; 20: 1–7. [DOI] [PubMed] [Google Scholar]
- 16. Hsu LA, Ko YL, Hsu KH, Ko YH, Lee YS: Genetic variations in the cholesteryl ester transfer protein gene and high density lipoprotein cholesterol levels in Taiwanese Chinese. Hum Genet 2002; 110: 57–63. [DOI] [PubMed] [Google Scholar]
- 17. Zheng K, Zhang S, Zhang L, He Y, Liao L, et al.: Carriers of three polymorphisms of cholesteryl ester transfer protein gene are at increased risk to coronary heart disease in a Chinese population. Int J Cardiol 2005; 103: 259–265. [DOI] [PubMed] [Google Scholar]
- 18. Castellani LW, Navab M, Van Lenten BJ, Hedrick CC, Hama SY, et al.: Overexpression of apolipoprotein AII in transgenic mice converts high density lipoproteins to proinflammatory particles. J Clin Invest 1997; 100: 464–474. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19. Nicholls SJ, Tuzcu EM, Schoenhagen P, Sipahi I, Crowe T, et al.: Effect of atorvastatin (80 mg/day) versus pravastatin (40 mg/day) on arterial remodeling at coronary branch points (from the REVERAL study). Am J Cardiol 2005; 96: 1636–1639. [DOI] [PubMed] [Google Scholar]
- 20. Niccoli G, Renda G, Cianflone D, Crea F: Transient microvascular vasoconstriction: a possible cause of unstable angina. Ital Heart J 2000; 1: 365–367. [PubMed] [Google Scholar]